>  
Report Detail

Medical Bionic Implants Market [Vision, Brain, Heart, Orthopedic & Ear] – Trends & Global Forecasts to 2017

Publisher Name :
Date: 1-Dec-2012
No. of pages: 298

Bionics is mechanical/electronic replacement or enhancement of organs/parts of living organisms. The medical bionic implants market is a potentially growing one with a global market of $12.67 billion in 2012. It is expected to grow at a CAGR of 7.1% to reach $17.82 billion in 2017.

The global medical bionic implants market has been segmented as vision bionics, ear bionics, orthopedic bionics, heart bionics, and neural/brain bionics. Heart bionics accounts for the largest share in this market, primarily due to a large global population with heart diseases. Rising healthcare expenditure and emergence of new healthcare facilities in emerging economies provides growth opportunities for the medical bionic implants market. The market for certain bionic devices such as exoskeletons, bionic orthopedics, and the bionic eye are skewed in favor of certain regions because of stronger research in these regions as compared to others. In this report, we are also focusing on bionic devices in pipeline, which include wearable artificial kidney, bio-lung, and artificial pancreas.

New and improved technologies, increasing organ failure owing to aging and age-related disorders, increasing accidents and injuries leading to amputations, and rise in number of people awaiting organ transplants are the major drivers slated to propel the growth of this market. However, a few pivotal factors restraining the growth of this market are high cost of devices and uncertain reimbursement scenarios in different regions, limited surgical expertise, and high cost of development. The opportunities in this market for new entrants include improving income levels, and rising awareness in emerging economies.

North America dominates the medical bionic implants market in 2012, followed by Europe. However, the adoption of novel medical bionics as a therapy in emerging markets is gaining momentum at a fast pace due to a growing population and increasing awareness among patients and players. In addition, increasing healthcare expenditure, growing income levels, rising preference for bionics due to better and efficient recovery as compared to prosthetics, growing surgical procedures in lieu with medical tourism, and lesser competition than mature countries, have amplified the interest of market players in emerging markets.

The key players in this market are Orthofix International N.V. (The Netherlands), Biomet, Inc. (U.S.), Medtronic, Inc. (U.S.), Cochlear Ltd. (Australia), Second Sight Medical Products, Inc. (U.S.), Ossur (Iceland), Ekso Bionics (U.S.), and St. Jude Medical, Inc. (U.S.).

Scope of the Report

This research report categorizes the global medical bionic implants market on the basis of products, technologies, and type of fixation. These markets are broken down into segments and sub-segments, providing value analysis for 2010, 2011, and 2012, as well as forecast up to 2017. Each market is comprehensively analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World) to provide in-depth information on the global scenario.

Global Medical Bionics Market, By Products

  • Vision Bionics
  • Bionic Eye

Ear Bionics

  • Cochlear Implant
  • Bone Anchored Hearing Aid (Baha)

Orthopedic Bionics

  • Bionic Limb
  • Bionic Hand
  • Bionic Leg
  • Bionic Knee
  • Bionic Feet
  • Bionic Finger
  • Exoskeleton
  • Electrical Bone Growth Stimulators
  • Invasive Bone Growth Stimulators
  • Non-Invasive Bone Growth Stimulators

Heart Bionics

  • Pacemaker
  • Implantable Cardiac Pacemaker
  • External Pacemaker
  • Total Artificial Heart
  • Ventricular Assist Device
  • Artificial Heart Valves
  • Mechanical Heart Valves
  • Tissue Heart Valves

Neural /Brain Bionics

  • Deep Brain Stimulator
  • Vagus Nerve Stimulator
  • Spinal Cord Stimulator

Global Medical Bionics Market, By Technology

  • Mechanical
  • Electronic

Global Medical Bionics Market, By Method of Fixation

  • Implantable
  • Externally Worn

Medical Bionics Market, By Geography

  • North America
  • Europe
  • Asia-Pacific
  • RoW

Medical Bionic Implants Market [Vision, Brain, Heart, Orthopedic & Ear] – Trends & Global Forecasts to 2017

Table Of Contents

1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.5.5 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 EVOLUTION
3.3 MARKET SEGMENTATION
3.4 BIONICS & PROSTHESES: SIMILARITIES & DIFFERENCES
3.5 MARKET DYNAMICS
3.5.1 DRIVERS
3.5.1.1 Technological advancements
3.5.1.2 Increasing organ failure owing to aging & age-related disorders
3.5.1.3 Increasing accidents & injuries leading to amputations
3.5.1.4 Rise in number of people awaiting organ transplants
3.5.2 RESTRAINTS
3.5.2.1 High cost of devices and uncertain reimbursement scenarios in different regions
3.5.2.2 Limited surgical expertise
3.5.2.3 High cost of development
3.5.3 OPPORTUNITIES
3.5.3.1 Advantageous in comparison prosthetics
3.5.3.2 Improving income levels & rising awareness could push demand in emerging economies
3.6 MARKET SHARE ANALYSIS
3.6.1 EAR BIONICS MARKET
3.6.2 ORTHOPEDIC BIONICS MARKET
3.6.3 HEART BIONICS MARKET
3.6.4 BRAIN/NEURAL BIONICS MARKET
3.7 EMERGING TECHNOLOGIES
3.7.1 BIONICS IN THE PIPELINE
3.7.1.1 Artificial Pancreas
3.7.1.2 Bio-Lung
3.7.1.3 Wearable Artificial Kidney

4 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY PRODUCTS
4.1 INTRODUCTION
4.2 VISION BIONICS
4.2.1 BIONIC EYE
4.3 EAR BIONICS
4.3.1 COCHLEAR IMPLANT
4.3.2 BONE ANCHORED HEARING AID (BAHA)
4.4 ORTHOPEDIC BIONICS
4.4.1 BIONIC LIMB
4.4.1.1 Bionic Hand
4.4.1.2 Bionic Leg
4.4.1.2.1 Bionic Knee
4.4.1.2.2 Bionic Feet
4.4.2 BIONIC FINGER
4.4.3 EXOSKELETON
4.4.4 ELECTRICAL BONE GROWTH STIMULATORS
4.4.4.1 Invasive Bone Growth Stimulators
4.4.4.2 Non-invasive Bone Growth Stimulators
4.5 HEART BIONICS
4.5.1 PACEMAKER
4.5.1.1 Implantable Cardiac Pacemaker
4.5.1.2 External Pacemaker
4.5.2 TOTAL ARTIFICIAL HEART
4.5.3 VENTRICULAR ASSIST DEVICE
4.5.4 ARTIFICIAL HEART VALVE
4.5.4.1 Mechanical Heart Valve
4.5.4.2 Tissue Heart Valve
4.6 NEURAL/BRAIN BIONICS
4.6.1.1 Deep Brain Stimulator
4.6.1.2 Vagus Nerve Stimulator
4.6.1.3 Spinal Cord Stimulator

5 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY TECHNOLOGY
5.1 INTRODUCTION
5.2 ELECTRONIC BIONICS
5.3 MECHANICAL

6 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY TYPE OF FIXATION
6.1 INTRODUCTION
6.2 EXTERNALLY WORN
6.3 IMPLANTABLE

7 GEOGRAPHIC ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.3 EUROPE
7.4 ASIA- PACIFIC
7.5 ROW

8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
8.2 MERGERS & ACQUISITIONS
8.3 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS
8.4 NEW PRODUCT LAUNCH
8.5 APPROVALS
8.6 EXPANSION
8.7 OTHER DEVELOPMENTS

9 COMPANY PROFILES (Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 ABIOMED, INC.
9.2 BERLIN HEART GMBH
9.3 BIOMET, INC.
9.4 BOSTON SCIENTIFIC CORPORATION
9.5 COCHLEAR, LTD.
9.6 EDWARDS LIFESCIENCES CORPORATION
9.7 EKSO BIONICS
9.8 HEARTWARE INTERNATIONAL, INC.
9.9 IWALK, INC.
9.10 JARVIK HEART, INC.
9.11 LIFENET HEALTH
9.12 MED-EL ELEKTROMEDIZINISCHE GERÄTE G.M.B.H.
9.13 MEDTRONIC, INC.
9.14 NANO RETINA, INC.
9.15 ORTHOFIX INTERNATIONAL N.V.
9.16 OSSUR
9.17 OTTO BOCK HEALTHCARE GMBH.
9.18 SECOND SIGHT MEDICAL PRODUCTS, INC.
9.19 SONOVA HOLDING AG
9.20 ST. JUDE MEDICAL, INC.
9.21 SORIN S.P.A.
9.22 TERUMO CORPORATION
9.23 THORATEC CORPORATION
9.24 TIBION CORPORATION
9.25 TOUCH BIONICS, LTD.

List Of Tables

TABLE 1 GLOBAL MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 2 MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 3 VISION BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 4 GLOBAL EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 5 EAR BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 6 COCHLEAR IMPLANT MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 7 BONE ANCHORED HEARING AID (BAHA) MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 8 GLOBAL ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 9 ORTHOPEDIC BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 10 GLOBAL BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 11 BIONIC LIMB MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 12 BIONIC HAND MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)
TABLE 13 GLOBAL BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 14 BIONIC LEG MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 15 BIONIC KNEE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 16 BIONIC FEET MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 17 BIONIC FINGER MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 18 EXOSKELETON MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 19 GLOBAL ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY PRODUCTS, 2010 – 2012 ($MILLION)
TABLE 20 ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 21 INVASIVE ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 22 NON INVASIVE ELECTRICAL BONE GROWTH STIMULATORS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 23 GLOBAL HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 24 HEART BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 25 GLOBAL PACEMAKER MARKET REVENUE, BY PRODUCTS, 2010 – 2012 ($MILLION)
TABLE 26 PACEMAKER MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 27 TOTAL ARTIFICIAL HEART MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 28 VENTRICULAR ASSIST DEVICES MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 29 GLOBAL ARTIFICIAL HEART VALVE MARKET REVENUE, BY PRODUCT TYPE, 2010 – 2017 ($MILLION)
TABLE 30 ARTIFICIAL HEART VALVE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 31 MECHANICAL HEART VALVE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 32 TISSUE HEART VALVE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 33 GLOBAL NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 34 NEURAL/BRAIN BIONICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 35 DEEP BRAIN STIMULATOR MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 36 VAGUS NERVE STIMULATOR MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 37 SPINAL CORD STIMULATOR MARKET REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 38 GLOBAL MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY TECHNOLOGY, 2010 – 2017 ($MILLION)
TABLE 39 GLOBAL MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY TYPE OF FIXATION, 2010 – 2017 ($MILLION)
TABLE 40 NORTH AMERICA: MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 41 NORTH AMERICA: EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 42 NORTH AMERICA: ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 43 NORTH AMERICA: BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 44 NORTH AMERICA: BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 45 NORTH AMERICA: ELECTRICAL BONE GROWTH STIMULATOR MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 46 NORTH AMERICA: HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 47 NORTH AMERICA: ARTIFICIAL HEART VALVE MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 48 NORTH AMERICA: NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)
TABLE 49 EUROPE: MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 50 EUROPE: EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 51 EUROPE: ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 52 EUROPE: BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 53 EUROPE: BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 54 EUROPE: ELECTRICAL BONE GROWTH STIMULATOR MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 55 EUROPE: HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 56 EUROPE: ARTIFICAL HEART VALVE MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 57 EUROPE: NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)
TABLE 58 ASIA-PACIFIC: MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 59 ASIA-PACIFIC: EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 60 ASIA-PACIFIC: ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 61 ASIA-PACIFIC: BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 62 ASIA-PACIFIC: BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 63 ASIA-PACIFIC: ELECTRICAL BONE GROWTH STIMULATOR MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 64 ASIA-PACIFIC: HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 65 ASIA-PACIFIC: ARTIFICIAL HEART VALVE MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 66 ASIA-PACIFIC: NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 67 ROW: MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 68 ROW: EAR BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 69 ROW: ORTHOPEDIC BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 70 ROW: BIONIC LIMB MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 71 ROW: BIONIC LEG MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 72 ROW: ELECTRICAL BONE GROWTH STIMULATOR MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 73 ROW: HEART BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 74 ROW: ARTIFICAL HEART VALVE MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 75 ROW: NEURAL/BRAIN BIONICS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
TABLE 76 MERGERS & ACQUISITIONS, 2010 –2012
TABLE 77 AGREEMENTS, PARTNERSHIPS & COLLABORATIONS, 2010 –2012
TABLE 78 NEW PRODUCT LAUNCH, 2010 –2012
TABLE 79 APPROVALS, 2010 –2012
TABLE 80 EXPANSION, 2010 – 2012
TABLE 81 OTHER DEVELOPMENTS, 2010 – 2012
TABLE 82 ABIOMED, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 83 ABIOMED, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 84 ABIOMED, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 85 BIOMET, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 86 BIOMET, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 87 BIOMET, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 88 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 89 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 90 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 91 COCHLEAR, LTD.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 92 COCHLEAR, LTD.: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 93 COCHLEAR, LTD.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 94 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE 2009 – 2011 ($MILLION)
TABLE 95 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 96 EDWARDS LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 97 HEARTWARE INTERNATIONAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 98 HEARTWARE INTERNATIONAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 99 MEDTRONIC, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 100 MEDTRONIC, INC.: TOTAL REVENUE, BY SEGMENTS, 2010 - 2012 ($MILLION)
TABLE 101 MEDTRONIC, INC.: CARDIAC AND VASCULAR GROUP REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 102 MEDTRONIC, INC.: RESTORATIVE THERAPIES GROUP REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 103 MEDTRONIC, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 104 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 105 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 106 ORTHOFIX INTERNATIONAL N V: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 107 OSSUR HF: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 108 OSSUR HF: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 109 OSSUR HF: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 110 OTTO BOCK HEALTHCARE GMBH: TOTAL REVENUE, 2009 – 2011 ($MILLION)
TABLE 111 OTTO BOCK HEALTHCARE GMBH. TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 112 OTTO BOCK HEALTHCARE GMBH: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 113 SONOVA HOLDING AG: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 114 SONOVA HOLDING AG: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 115 SONOVA HOLDING AG: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 116 ST. JUDE MEDICAL, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 117 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 118 ST. JUDE MEDICAL, INC.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 119 SORIN S.P.A.: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 120 SORIN S.P.A.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011 ($MILLION)
TABLE 121 SORIN S.P.A.: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)
TABLE 122 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2010 – 2012 ($MILLION)
TABLE 123 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2010 – 2012 ($MILLION)
TABLE 124 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2010 – 2012 ($MILLION)
TABLE 125 THORATEC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 – 2011 ($MILLION)
TABLE 126 THORATEC CORPORATION: TOTAL REVENUE, BY PRODUCTS LINES, 2009 – 2011 ($MILLION)
TABLE 127 THORATEC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, 2009 – 2011 ($MILLION)

List Of Figures

FIGURE 1 GLOBAL MEDICAL BIONIC IMPLANTS MARKET REVENUE, BY PRODUCTS, 2010 – 2017 ($MILLION)
FIGURE 2 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY SEGMENTS
FIGURE 3 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY PRODUCTS
FIGURE 4 MEDICAL BIONIC IMPLANTS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 5 EAR BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 6 ORTHOPEDIC BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 7 HEART BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 8 BRAIN/NEURAL BIONICS MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 9 CLASSIFICATION OF ORTHOPEDIC BIONICS
FIGURE 10 CLASSIFICATION OF BIONIC LIMBS
FIGURE 11 CLASSIFICATION OF ELECTRICAL BONE GROWTH STIMULATORS
FIGURE 12 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY TECHNOLOGY
FIGURE 13 GLOBAL MEDICAL BIONIC IMPLANTS MARKET, BY TYPE OF FIXATION
FIGURE 14 KEY GROWTH STRATEGIES, 2010 – 2012

  • Most Effective Treatments For Diabetes
    Diabetes is a chronic metabolic disease leading to high blood sugar because or troubled insulin secretion. There are two types of diabetes – type 1 and type 2. Type 1 or juvenile diabetes causes when the body fails to produce enough insulin. Type 2 on the other hand causes when the body cells have lower [...]
  • Importance of Educational Books Publishing
    Education plays a crucial role in overall development of a person and the entire society. Students across the globe and various educational levels depend on study material. Whether they are textbooks, reference books or workbooks, they are in a constant need for systematic educational books. Educational book publishing is a versatile crucial branch of book [...]
  • How to Treat Arthritis Effectively ?
    The word arthritis stands for inflammation of joints. It is an umbrella term for over 100 diseases that cause pain, discomfort, disability and several other symptoms amongst individuals. Osteoarthritis is one of the most common types of arthritis, which affects elderly. Several other forms of this disease may affect individuals at a very young age [...]
  • Benefits of Set top Boxes Amidst the Wave of Digitization
    A set top unit or box is a useful device that provides content through television sets. Set top box is a term that refers to a device, which is used for broadcasting the content. It is different from the devices that help simple recording of media, such as DVDs. Cable operators and satellite companies provide [...]
  • What are the Treatments for Alzheimer’s Disease ?
    Alzheimer’s disease is one of the most common types of dementia. Dementia is the condition defined by significant loss of global cognitive ability in a healthy person. This loss is beyond the normal aging process and it only worsens with the age. Alzheimer’s disease is a serious mental health condition and a progressive brain disease [...]
  • Foresight 2020: Network Development in a Multi-Channel World

    • London, May 24th, 2013 – As the costs of branch banking increased in the 80s and 90s, banks attempted to reduce costs by reliance on centers, mobile and online channels to lower costs and improve service. The digitization of banks …

  • Italy Healthcare Industry Regulatory and Reimbursement Landscape

    • The Italian Pharmaceutical Market has Declined in Value Terms Due to the Introduction of Price Cuts and Increasing Focus on the Usage of Generic Drugs in Order to Rein in Ballooning Healthcare Expenditure   The pharmaceutical market (at the consumer …

  • Men’s Health & Midlife Women Consumer Market Research Reports

    • RnRMarketResearch.com offers new market research reports on masculinity Vs health and midlife women embracing power and avoiding invisibility in global consumer markets.   “Masculinity Vs Health: Challenges and Opportunities” and “Midlife Women: Embracing Power and Avoiding Invisibility in Global Consumer …

  • France Healthcare Market Regulatory and Reimbursement Landscape

    • France has a Mature Healthcare Market as it Offers Universal Public Access to Healthcare Facilities and Insurance. The Increasing Disease Burden and the Launch of New Products will Drive the Growth of the Pharmaceutical Market; however, Increasing Focus on Generics …

  • Lebanon Cards and Payments Industry Worth 2.4 Million Cards By 2017

    • Between 2008 and 2012, Lebanon’s cards industry recorded a CAGR of 4.89% in terms of volume and the total number of cards increased from 1.6 million to 2.0 million. The industry has been forecasted to grow at a CAGR of …

  • 2013 Deep Research Report on China Denture Industry
    "......, Macroeconomic environment and economic situation analysis and influence, Denture  industry policy and plan, Denture  product specification, manufacturing process, product cost structure etc. then statistics China key manufacturers Denture  capac......"
  • The Global Market for Advanced Microscopes (Electron and Scanning Probe) to 2020
    "......e microscopes are in Asia-Pacific and USA. The market is dominated by a number of multi-nationals and is intensely competitive and characterized by rapid technological change. Companies are expecting an uncertain market environment in 2013. Indust......"
  • MediFocus: Medical Devices for the Treatment of Obesity
    "......gical intervention. Less-invasive that surgery, obesity treatment medical devices have seen notable advancement in recent years, and several technologies have gained international adoption; however, long-term efficacy is still lacking, prompting cont......"
  • Medical Equipment Monthly Deals Analysis: April 2013 – M&A and Investment Trends
    "......p;As, equity/debt offerings, private equity, venture financing and partnership transactions registered in the medical equipment industry in April 2013. The report portrays detailed comparative data on the number of deals and their value in the last s......"
  • Changing Regulatory and Reimbursement Scenario for Medical Devices in the US Market
    "......and endoscopy devices. The report provides comprehensive information on establishment registration, medical device listing, Premarket Notification (510k) or Premarket Approval (PMA), Investigational Device Exemption (IDE) for clinical studies, Qualit......"